KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Other Non-Current Assets (2016 - 2020)

Historic Other Non-Current Assets for Abbott Laboratories (ABT) over the last 12 years, with Q4 2020 value amounting to $824.0 million.

  • Abbott Laboratories' Other Non-Current Assets rose 1994.18% to $824.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $824.0 million, marking a year-over-year increase of 1994.18%. This contributed to the annual value of $824.0 million for FY2020, which is 1994.18% up from last year.
  • Latest data reveals that Abbott Laboratories reported Other Non-Current Assets of $824.0 million as of Q4 2020, which was up 1994.18% from $687.0 million recorded in Q4 2019.
  • In the past 5 years, Abbott Laboratories' Other Non-Current Assets registered a high of $2.8 billion during Q3 2016, and its lowest value of $19.0 million during Q3 2018.
  • Moreover, its 5-year median value for Other Non-Current Assets was $635.0 million (2018), whereas its average is $1.1 billion.
  • As far as peak fluctuations go, Abbott Laboratories' Other Non-Current Assets surged by 252190.48% in 2016, and later crashed by 9794.89% in 2017.
  • Abbott Laboratories' Other Non-Current Assets (Quarter) stood at $2.8 billion in 2016, then crashed by 93.61% to $176.0 million in 2017, then skyrocketed by 231.25% to $583.0 million in 2018, then rose by 17.84% to $687.0 million in 2019, then grew by 19.94% to $824.0 million in 2020.
  • Its Other Non-Current Assets stands at $824.0 million for Q4 2020, versus $687.0 million for Q4 2019 and $583.0 million for Q4 2018.